- News
- 108 views
At Cifga, we are introducing a new product category within our catalogue, expanding our offering beyond the agri-food and textile sectors to address the growing needs of the pharmaceutical industry.
Until now, our portfolio has included certified reference materials (CRM) and quality controls (QC) mainly focused on the analysis of marine toxins, cyanotoxins, and mycotoxins in the agri-food sector, as well as analytical kits for textile applications. With this expansion, we take a strategic step into a key new field: Pharma.
New standards for the pharmaceutical sector
At Cifga, we are expanding our product portfolio with the addition of pharmaceutical impurity standards, including nitrosamine standards, one of the most relevant groups of compounds in current pharmaceutical quality control due to their regulatory impact and the stringent requirements of international agencies.
Initially, these products will be available as quality control (QCs) solutions, and in a later phase they will be developed into certified reference materials (CRM), further strengthening our commitment to traceability, analytical reliability, and regulatory compliance.
A strategic step for the sector
The introduction of this new product line represents a significant milestone both for Cifga and for the pharmaceutical industry, in a context where demand for high-quality impurity standards is continuously increasing worldwide.
With this expansion, we reaffirm our commitment to developing precise, reliable analytical solutions fully aligned with international regulatory requirements.
Stay informed
We will continue to progressively expand this new category within our catalogue. We invite our customers and partners to stay tuned for upcoming updates and to be among the first to access Cifga’s high-quality nitrosamine standards.
At Cifga, we continue moving forward with a clear goal: to provide reference analytical tools that contribute to safety, quality, and confidence across all the sectors we serve.
.jpg)